| Product Name | MF | CAS | Details |
|---|
| CpCDPK1/TgCDPK1-IN-1 | C18H17N5 | 1092788-23-2 | Details |
| LSD1-IN-27 | C24H25N3 | 2904571-94-2 | Details |
| Tubulin polymerization-IN-43 | C17H13F4N3O | 2773345-90-5 | Details |
| Tubulin polymerization-IN-55 | C22H24N2O4 | 2942396-29-2 | Details |
| SARS-CoV-2 3CLpro-IN-16 | C17H14N2OS | 352659-40-6 | Details |
| ADS032 | C22H29NO4S | 2757333-37-0 | Details |
| Trontinemab | 2568868-35-7 | Details |
| Antiviral agent 34 | 945152-88-5 | Details |
| Zharp2-1 | 2772600-18-5 | Details |
| S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
| Clozapine Analogues | 124380-97-8 | Details |
| Aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| a-MSH, amide Acetate(581-05-5 free base) | C77H109N21O19S | 581-05-5 | Details |
| D4R agonist-1 | 2826198-44-9 | Details |
| LCC-12 FA | 3029253-76-4 | Details |
| MM0299 | C26H23NO5 | 474255-10-2 | Details |
| AVN 322 free base | C17H19N5O2S | 1194574-33-8 | Details |
| EBOV-IN-1 | C34H43N3O5 | 1335113-30-8 | Details |
| Enpp-1-IN-16 | C23H32N4O4 | 2289739-47-3 | Details |
| RN-1665 | C20H24F5N3O3S2 | 1803003-65-7 | Details |
| MoTPS1-IN-1 | C23H27F3N2O4 | 2991072-02-5 | Details |
| IR820-PTX | 2250419-19-1 | Details |
| 3,3'-Selenobisalanine | 61216-56-6 | Details |
| VUN65671 | C25H30F3N3O2 | 2479465-67-1 | Details |
| Ipamorelin 2 Pivalic acid | C38H49N9O5 | 170851-70-4 | Details |
| KSK94 | 2566716-07-0 | Details |
| Z16078526 | 852222-94-7 | Details |
| LW3 | C17H12F3N3O | 2803367-68-0 | Details |
| Aneratrigine hydrochloride | 2097163-75-0 | Details |
| AST 7062601 | C18H15N3O4S | 675197-89-4 | Details |
| Usenamine A | C18H17NO6 | 1428417-60-0 | Details |
| PAC1R antagonist 1 | C17H17ClN6O2 | 2305204-24-2 | Details |
| KSK68 | 2566715-91-9 | Details |
| AKE-72 | C30H29F3N6O | 2566525-18-4 | Details |
| OPC18750 HCl | 145364-90-5 | Details |
| 1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| Tenilapine | 82650-83-7 | Details |
| AMPK activator 12 | C23H24BrNO2 | 431920-24-0 | Details |
| (S)-OSMI 3 | 2411972-78-4 | Details |
| CI 169369 | C19H21ClN2S | 85273-96-7 | Details |
| (R)-Monepantel | C20H13F6N3O2S | 887148-70-1 | Details |
| Lingdolinurad | C17H12BrN3O2 | 2088176-96-7 | Details |
| TNF/IFNγ-IN-1 | C20H23N3O6 | 876013-29-5 | Details |
| Antimalarial agent 30 | 1597425-64-3 | Details |
| MC4033 | C16H13N3O3 | 28532-21-0 | Details |
| SQLE-IN-1 | C24H21F2N5O2S | 1019169-83-5 | Details |
| OX04528 | C16H13F6NO2 | 3028055-45-7 | Details |
| KM02894 | C7H9N3OS2 | 116850-74-9 | Details |
| Relenopride | C24H30ClFN4O4 | 1221416-43-8 | Details |
| LFHP-1c | C55H64N6O4 | 2102347-47-5 | Details |
| DJ4 | C19H16N4OS | 1681020-24-5 | Details |
| MMP-9-IN-6 | C25H19NO2 | 2241964-36-1 | Details |
| EGFR-IN-87 | C28H33N7O2 | 1835666-87-9 | Details |
| SARS-CoV-2-IN-38 | 2882823-27-8 | Details |
| TIM-3-IN-2 | C25H23N3O6 | 1113126-49-0 | Details |
| (S)-VB 201 | 936227-77-9 | Details |
| Topoisomerase II inhibitor 14 | C15H11Cl2N5 | 305343-00-4 | Details |
| Fenclozine Maleate | C45H47ClN2O12 | 76823-82-0 | Details |
| 1-N-Methyl-4-mercaptohistidine disulfide | 73491-33-5 | Details |
| PLpro/RBD-IN-1 | C13H10N4O | 1282451-83-5 | Details |
| Tubulin inhibitor 32 | 2923531-39-7 | Details |
| PI3Kδ-IN-16 | C22H26N6O2 | 2766437-35-6 | Details |
| DHX9-IN-2 | C18H16ClN3O3S2 | 2973395-71-8 | Details |
| QST4 | C16H13ClN4O2S2 | 2991427-35-9 | Details |
| EGFR/ErbB-2 inhibitor-1 | 1135150-79-6 | Details |
| Estrogen receptor antagonist 8 | 2889370-92-5 | Details |
| (Z)-Tenilapine | 82650-82-6 | Details |
| Safingol hydrochloride | C18H39NO2. HCl | 139755-79-6 | Details |
| JHU 75528 | C23H21Cl2N5O2 | 947696-17-5 | Details |
| Phosphatase-IN-1 | 2889356-55-0 | Details |
| Anti-inflammatory agent 49 | C21H22N8O3S | 851471-44-8 | Details |
| BIIB 722 Mesylate | C19H23F3N6O5S | 261505-81-1 | Details |
| 20-HETE Intermediate 15 | C23H36O4 | 1286736-37-5 | Details |
| IMMH 010 maleate | C36H36BrClN2O9 | 2541982-47-0 | Details |
| B-Raf IN 16 | C20H19N5O3S | 2304746-24-3 | Details |
| CCG-13514 | C25H25BrN2O2 | 423741-32-6 | Details |
| h-NTPDase-IN-2 | 2939933-03-4 | Details |
| ALK-IN-26 | C24H23NO3S | 2447607-85-2 | Details |
| XPW1 | C36H39ClFN7O2 | 2700286-66-2 | Details |
| AS601245.2TFA (345987-15-7 free base) | C20H16N6S.2C2HF3O2 | 345987-16-8 | Details |
| (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | C16H23N3O2.C4H6O6 | 2919211-45-1 | Details |
| NSC 122393 | C20 H8 Br4 O5 | 73654-97-4 | Details |
| VU534 | C21H22FN3O3S2 | 923509-20-0 | Details |
| IRG1-IN-1 | C18H15FO4 | 2407652-42-8 | Details |
| AC-099 hydrochloride | C9H9Cl2F3N4 | 849335-07-5 | Details |
| Cloroperone | C22H23ClFNO2 | 61764-61-2 | Details |
| A09-003 | 2911646-14-3 | Details |
| Sulcardine 2HCl | 343935-48-8 | Details |
| h-NTPDase-IN-3 | 2939933-10-3 | Details |
| Anti-inflammatory agent 51 | C22H22N6O6S | 2911610-03-0 | Details |
| 17β-HSD10-IN-1 | C16H13ClN4O3S | 2316765-78-1 | Details |
| TIE-2/VEGFR-2 kinase-IN-5 | 1014407-83-0 | Details |
| Ogremorphin | C21H17N3OS | 352563-21-4 | Details |
| MY-1076 | C29H33NO9 | 3008262-76-5 | Details |
| Nrf2 activator-3 | 2766570-23-2 | Details |
| IDH2R140Q-IN-2 | 2749568-16-7 | Details |
| JG-2016 | C18H21ClN4O3 | 2887480-87-5 | Details |
| 3,5,6-trihydroxysitostane | C29H52O3 | 133697-68-4 | Details |
| KSK67 | C22H27N3O2 | 2566715-93-1 | Details |
| LSD1-IN-30 | C15H14N2O3 | 1289575-45-6 | Details |
| Product Total： Product Page： | ||||
| 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 | ||||